27
12
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T22708 |
Darglitazone
CP-86325 |
PPAR | DNA Damage/DNA Repair; Metabolism |
Darglitazone (CP-86325) 是一种噻唑烷二酮,是口服有效的PPAR-γ选择性激动剂。Darglitazone 可以有效控制血糖和脂质代谢,在 II 型糖尿病中有研究价值。 | |||
T1461 |
Candesartan
CV 11974,坎地沙坦 |
RAAS | Endocrinology/Hormones |
Candesartan (CV 11974) 是一种血管紧张素II 受体拮抗剂(IC50:0.26 nM)。 | |||
TQ0156 |
GW1929
|
PPAR | DNA Damage/DNA Repair; Metabolism |
GW1929是PPAR-γ有效激动剂,对人PPAR-γ的pKi 为8.84。对人和鼠的pEC50分别为8.56 和 8.27。 | |||
T15575 |
Indeglitazar
PPM 204 |
PPAR | DNA Damage/DNA Repair; Metabolism |
Indeglitazar (PPM 204) 是 PPAR 的泛激动剂,包括亚型 alpha (α)、delta (δ) 和 gamma (γ)。 | |||
T27303 |
Farglitazar
GI-262570,GI 262570,GI262570 |
||
Farglitazar is a PPAR-γ agonist. GI262570 stimulates the ENaC and Na,K-ATPase system resulting in the increasing of water and sodium reabsorption in distal nephron. | |||
T21587 |
Muraglitazar
Pargluva,BMS-298585 |
PPAR | DNA Damage/DNA Repair; Metabolism |
Muraglitazar (BMS-298585) 是一种 PPAR α/γ的双激动剂,用于治疗2型糖尿病及相关血脂异常。Muraglitazar 对人 PPARα (EC50 = 320 nM)和 PPARγ(EC50 = 110 nM)具有较强的体外活性。 | |||
T28589 |
Ro 41-5253
Ro-41-5253,Ro 415253 |
Apoptosis; Retinoid Receptor | Apoptosis; Metabolism |
Ro 41-5253 是一种具有口服活性的 RARα 拮抗剂,是过氧化物酶体增殖物激活受体 (PPAR)-γ 的配体和部分激动剂,具有抗肿瘤活性,抑制 MCF-7 和 ZR-75.1 雌激素受体阳性乳腺癌细胞的增殖并诱导细胞凋亡。 | |||
T8780 |
AMG131
INT-131,AMG-131,CHS 131 |
PPAR | DNA Damage/DNA Repair; Metabolism |
AMG131 (CHS 131) 是一种新型非噻唑烷二酮(TZD) 选择性过氧化物酶体增殖物激活受体 (PPAR) γ 调节剂,可用于治疗 2 型糖尿病。 | |||
T16739 |
RG-12525
NID 525 |
Leukotriene Receptor; PPAR | DNA Damage/DNA Repair; GPCR/G Protein; Metabolism |
RG-12525(NID 525) 是一种可口服且具有选择性和竞争性的白三烯 D (LTD)拮抗剂,对 LTC4,LTD4 和 LTE4 诱导的豚鼠薄壁带收缩有抑制作用,IC50 值分别为 2.6 nM,2.5 nM 和 7 nM。RG-12525 对 CYP3A4 有抑制作用, Ki 值为 0.5 µM。RG-12525 是一种新型高效的 PPAR-γ 激动剂(IC50 值约为 60 nM),具有物种特异性,可用于研究哮喘。 | |||
T7621 |
6-Thioinosine
6-Mercaptopurine riboside,6-疏基嘌呤核苷,6TI |
Nucleoside Antimetabolite/Analog | Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
6-Thioinosine (6TI) 是一种嘌呤抗代谢物,是抗脂肪形成剂,能降低PPAR γ和C/EBPα及其目标基因 aP2、CD36、LPL 和 LXRα 的 mRNA 水平。 | |||
T16022 |
Arhalofenate
JNJ 39659100,芳卤芬酯,4-氯-ALPHA-[3-(三氟甲基)苯氧基]苯乙酸 2-(乙酰基氨基)乙酯,MBX 102 |
PPAR | DNA Damage/DNA Repair; Metabolism |
Arhalofenate (JNJ 39659100) 是一种选择性的(PPAR)-γ部分激动剂,用于研究 2 型糖尿病。 | |||
T17044 |
Tesaglitazar
|
PPAR | DNA Damage/DNA Repair; Metabolism |
Tesaglitazar 是一种有效且具有选择性的过氧化物 PPAR α / γ受体双重激动剂,对 PPARγ的亲和力比 PPARα更有效,对大鼠PPARα和人PPARα的EC50分别为13.4 μM 和3.6 μM,对大鼠PPARγ和人类 PPARγ的EC50都是0.2 μM。Tesaglitazar 诱导大鼠皮下组织间质间充质细胞DNA 合成和纤维肉瘤形成。 | |||
T10506 |
PPAR agonist 1
|
PPAR | DNA Damage/DNA Repair; Metabolism |
PPAR agonist 1 is an agonist of PPAR α/γ, used for reducing blood glucose, lipid levels, reducing body weight, and lowering cholesterol. | |||
T27513 |
GW7845
GW 7845,GW-7845 |
||
GW7845, an L-tyrosine derivative, is a PPAR-γ agonist. | |||
T28542 |
Rivoglitazone HCl
CI-1037,CI1037,CS011,CS-011,CI 1037 |
||
Rivoglitazone, also known as CI-1037; CS-011; DE-101; R-119702; Rivo, is a peroxisome proliferator-activated receptor γ agonist (PARPγ agonist) potentially for the treatment of type 2 diabetes. Rivoglitazone has been shown, through small clinical studies, | |||
T10596 |
BR102375
|
Others | Others |
BR102375 is a non-TZD PPAR γ full agonist (EC50: 0.28 μM) for the treatment of type 2 diabetes. | |||
T78582 |
15-keto-Prostaglandin E2
15-keto-PGE2 |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
15-keto-Prostaglandin E2为内源性代谢产物,通过与STAT3Cys259残基结合,抑制STAT3激活作用。该化合物能够结合并稳定EP2与EP4受体,进而抑制乳腺癌细胞生长与进展,并通过激活PPAR-γ促进真菌生长。 | |||
T33415 |
MK 0767
MK0767,MK-0767 |
||
MK 0767 is a dual peroxisome proliferator-activated receptor (PPAR) α/γ agonist that has been investigated as a potential treatment for type 2 diabetes and dyslipidemia. | |||
T62576 |
Darglitazone Sodium
|
||
Darglitazone Sodium 是一种噻唑烷二酮,是一种选择性的、口服具有活力的 PPAR-γ (过氧化物酶体增殖物激活受体)激动剂。Darglitazone Sodium 可以有效控制血糖和脂质代谢,能够用于研究 II 型糖尿病。 | |||
T81121 | SP4e | PPAR | DNA Damage/DNA Repair; Metabolism |
SP4e是一种PPAR-γ激活剂,其在HK-2细胞中展现出的EC50为739 nM。在瑞士白化病小鼠模型中,SP4e能有效降低血糖和脂质过氧化水平,并提升谷胱甘肽含量及过氧化氢酶的活性。 | |||
T79231 | DSO-5a | PPAR | DNA Damage/DNA Repair; Metabolism |
DSO-5a为具口服活性的BB3激动剂,兼具效力与选择性。此化合物为DMAKO-00系列衍生物,能够通过BB3提升ppar-γ功能并促进ERK1/2的磷酸化。DSO-5a主要应用于糖尿病领域的研究。 | |||
T37579 |
GW 1929 hydrochloride
|
||
Highly selective orally active peroxisome proliferator-activated receptor (PPAR)γ agonist (pEC50 values are 8.05, < 4 and < 4 for human PPARγ, PPARα and PPARδ receptors respectively). Decreases glucose, fatty acid and triglyceride levels following oral administration in vivo. Brown et al (1999) A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-γ reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes 48 1415 PMID:10389847 |Nugent et al (2001) Pote... | |||
T81120 | SP4f | PPAR | DNA Damage/DNA Repair; Metabolism |
SP4f为PPAR-γ激活剂,其在HK-2细胞中EC50值为826 nM。在瑞士白化病小鼠中,SP4f能够降低血糖和脂质过氧化水平,同时提升谷胱甘肽含量和过氧化氢酶活性。 | |||
T37829 |
CAY10573
|
||
The peroxisome proliferator-activated receptors (PPARs) are lipid-activated transcription factors often used as drug targets for the treatment of metabolic disorders. CAY10573 is a PPAR agonist that displays potent binding at PPARα, γ, and δ with IC50 values of 113, 50, and 223 nM, respectively. It potently transactivates PPARα, γ, and δ with EC50 values of 8, 70, and 500 nM, respectively. CAY10573 demonstrates stronger binding and functional activity for PPARγ than the antidiabetic compound ros... | |||
T69671 | SR1903 TFA | ||
SR-1903 is a modulator of retinoic acid receptor-related orphan receptor γ (RORγ) and liver X receptor (LXR). It is an inverse agonist of RORγ and an agonist of LXR. It also binds to peroxisome proliferator-activated receptor γ (PPAR) but does not activate it. SR-1903 inhibits LPS-induced expression of triggering receptor expressed on myeloid cells 1 (TREM-1). It also inhibits LPS-induced expression of the LXR target genes IL-6 and IL-33 and increases expression of ABCG1, FASN, and SCD-1. SR-190... | |||
T61976 |
DS-6930
|
||
DS-6930 是一种有效的和选择性的 PPARγ激动剂(EC50= 41 nM)。DS-6930 可有效降低血浆葡萄糖 (PG)水平,此外,与 Rosiglitazone 相比,具有更少的 PPARγ 相关不良反应。DS-6930 在糖尿病中具有研究价值。 | |||
T35813 |
CAY10592
|
||
Peroxisome proliferator-activated receptors (PPARs) α, δ, γ are ligand-activated nuclear transcription factors involved in the regulation of energy homeostasis as well as insulin sensitivity and glucose metabolism. Pharmacologies of PPARδ receptor agonists, though relatively obscure, have recently been reported to elevate high-density lipoprotein (HDL) cholesterol and lower plasma triglyceride (TG) levels in obese insulin resistant rhesus monkeys. CAY10592 is a full PPARδ agonist (EC50 = 30 nM) ... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1633 |
β-Carotene
beta-胡萝卜素,Carotaben,Beta-Carotene,Provitamin A,β-胡萝卜素 |
Apoptosis; ROS; Endogenous Metabolite | Apoptosis; Immunology/Inflammation; Metabolism |
β-Carotene (Provitamin A) 是一种天然存在的视黄醇(维生素 A)前体。它是一种 ROS 调节剂,具有抗氧化和抗炎活性。它可作为抗氧化剂或者促氧化剂,可诱导乳腺癌细胞凋亡,具有抗癌活性。 | |||
TN1693 |
Glabrone
|
Influenza Virus; PPAR | DNA Damage/DNA Repair; Metabolism; Microbiology/Virology |
Glabrone 是从甘草根中分离的一种异黄酮,可与 PPAR-γ 配体结合,具有抗流感活性。 | |||
T2946 |
Tanshinone IIA sulfonate sodium
丹参酮IIA磺酸盐,丹参酮IIA-磺酸钠,Tanshinone IIA sulfonate,Sodium Tanshinone IIA sulfonate,Tanshinone IIA sodium sulfonate,sodium |
CaMK; P450; Calcium Channel | Membrane transporter/Ion channel; Metabolism; Neuroscience |
Tanshinone IIA sulfonate sodium (Tanshinone IIA sodium sulfonate) 是从丹参中提取的丹参酮IIA 的水溶性衍生物,是SOCE 抑制剂,用于心血管疾病的研究。 | |||
T6S0117 |
Avicularin
Fenicularin,扁蓄苷 |
ERK | MAPK |
Avicularin (Fenicularin) 具有抗过敏、抗炎、保肝、抗氧化、抗肿瘤等活性。它能通过调节 NF-κB(p65)、COX-2 和 PPAR-γ 的活性来改善人类肝细胞癌。在 LPS 刺激的 RAW 264.7 巨噬细胞中,它通过抑制 ERK 信号通路产生抗炎活性。 | |||
T2932 |
Ginsenoside Rh1
Sanchinoside B2,人参皂苷 Rh1,人参皂苷Rh1,Prosapogenin A2,20(S)-Ginsenoside Rh1,Sanchinoside Rh1 |
IL Receptor; TNF; Endogenous Metabolite; PPAR; Interleukin | Apoptosis; DNA Damage/DNA Repair; Immunology/Inflammation; Metabolism |
Ginsenoside Rh1 (Sanchinoside B2) 是人参的一种主要成分,具有抗炎作用,抑制PPAR-γ,TNF-α,IL-6和IL-1β的表达。 | |||
TN1018 |
Angeloylgomisin H
当归酰戈米辛 H,当归酰戈米辛H |
PPAR | DNA Damage/DNA Repair; Metabolism |
Angeloylgomisin H 是从五味子中提取的一种木脂素类天然产物。它通过激活PPAR-γ来改善胰岛素刺激的葡萄糖摄取潜力。 | |||
TN2601 |
12-O-Methylcarnosic acid
|
Reductase | Endocrinology/Hormones; Metabolism |
12-O-Methylcarnosic acid 是分离自小叶丹参的丙酮提取物的一种二萜肉桂酸,可抑制 5α-还原酶 (5α-reductase) 活性,IC50为 61.7 μM。它抑制 LNCaP 细胞的增殖。它具有抗微生物活性、抗氧化和抗癌活性。 | |||
T4956 |
Tetrahydroxystilbene-2-O-β-D-glucoside
tetrahydroxyl diphenylethylene-2-o-gluco,何首乌苷,EH-201 |
Others | Others |
Tetrahydroxystilbene-2-O-β-D-glucoside (EH-201) 是一种低分子量的促红细胞生成素诱导剂。 | |||
T3867 |
Alpinetin
山姜素,(-)-alpinetin |
BCL; PPAR | Apoptosis; DNA Damage/DNA Repair; Metabolism |
Alpinetin ((-)-alpinetin) 是从草豆蔻中分离得到的一种黄酮类天然产物,能够活化PPAR-γ,具有抗炎、抗菌活性。它通过抑制增殖、调节 Bcl-2 家族和 XIAP 表达、释放细胞色素 c 和激活 caspase 具有很强的抗肝癌和胰腺癌细胞作用。 | |||
TN4860 |
Pueroside B
|
COX; PPAR | DNA Damage/DNA Repair; Immunology/Inflammation; Metabolism; Neuroscience |
Pueroside B may can treat coronary heart disease, it can interact with two or more targets[peroxisome proliferator activated receptor γ (PPAR-γ), angiotensin-converting enzyme (ACE), hydroxymethylglutaryl coenzyme A receptor (HMGR), cyclooxygenase-2 (COX2 | |||
TN3219 |
7,8-Didehydrocimigenol
|
ERK; IκB/IKK; TNF; NF-κB; Akt; PPAR | Apoptosis; Cytoskeletal Signaling; DNA Damage/DNA Repair; MAPK; Metabolism; NF-κB; PI3K/Akt/mTOR signaling |
7,8-Didehydrocimigenol can be used for the treatment of cardiovascular disorders such as atherosclerosis. It upregulates PPAR-γ in EC inhibits NF-kB activity of TNF-α-activated EC which leads to selective inhibition of VCAM-1 expression. | |||
TN3655 |
Cimiside E
|
ERK; TNF; ROS; Akt; PI3K; PKC; PPAR | Apoptosis; Chromatin/Epigenetic; Cytoskeletal Signaling; DNA Damage/DNA Repair; Immunology/Inflammation; MAPK; Metabolism; PI3K/Akt/mTOR signaling |
Cimiside E has anti-inflammatory activity, it selectively inhibits TNF-α-induced expression of VCAM-1 at least by upregulation of PPAR-γ, and signals for ERK1/2, PI3K, and PKC are involved in this effect.Cimiside E may be an effective chemopreventive agen |